SIGA (SIGA) 10-Q 8 Aug 23 2023 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Jul. 24, 2023
Document Information [Line Items]
Entity Central Index Key	0001010086
Entity Registrant Name	Siga Technologies INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	0-23047
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3864870
Entity Address, Address Line One	31 East 62nd Street
Entity Address, Postal Zip Code	10065
Entity Address, City or Town	New York
Entity Address, State or Province	NY
City Area Code	212
Local Phone Number	672-9100
Title of 12(b) Security	common stock, $.0001 par value
Trading Symbol	SIGA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		71,082,944

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 76,213,484	$ 98,790,622
Accounts receivable	6,026,887	45,406,960
Inventory	50,497,103	39,273,090
Prepaid expenses and other current assets	1,560,626	2,315,672
Total current assets	134,298,100	185,786,344
Property, plant and equipment, net	1,605,222	1,848,314
Deferred tax asset, net	7,591,743	6,250,385
Goodwill	898,334	898,334
Other assets	2,117,360	252,546
Total assets	146,510,759	195,035,923
Current liabilities
Accounts payable	1,081,337	3,355,268
Accrued expenses and other current liabilities	17,894,986	16,852,781
Income tax payable	11,822	1,309,672
Total current liabilities	18,988,145	21,517,721
Other liabilities	3,448,558	3,358,160
Total liabilities	22,436,703	24,875,881
Commitments and contingencies
Stockholders’ equity
Common stock ($.0001 par value, 600,000,000 shares authorized, 71,082,944 and 72,675,190, issued and outstanding at June 30, 2023 and December 31, 2022, respectively)	7,109	7,268
Additional paid-in capital	234,873,128	233,957,767
Accumulated deficit	(110,806,181)	(63,804,993)
Total stockholders’ equity	124,074,056	170,160,042
Total liabilities and stockholders’ equity	$ 146,510,759	$ 195,035,923

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares issued (in shares)	71,082,944	72,675,190
Common stock, shares outstanding (in shares)	71,082,944	72,675,190

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive (Loss)/Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Total revenues	$ 5,878,166	$ 16,667,045	$ 14,201,190	$ 27,206,345
Operating expenses
Cost of sales and supportive services	974,420	882,096	2,124,608	5,602,212
Selling, general and administrative	4,425,959	5,874,139	8,661,068	9,585,427
Research and development	5,116,154	6,840,099	10,162,189	10,386,876
Total operating expenses	10,516,533	13,596,334	20,947,865	25,574,515
Operating (loss)/income	(4,638,367)	3,070,711	(6,746,675)	1,631,830
Gain from change in fair value of warrant liability	0	49,559	0	400,663
Other income, net	1,190,705	72,373	2,081,334	95,694
(Loss)/income before income taxes	(3,447,662)	3,192,643	(4,665,341)	2,128,187
Benefit/(Provision) for income taxes	572,186	(1,155,581)	871,608	(452,175)
Net and comprehensive (loss)/income	$ (2,875,476)	$ 2,037,062	$ (3,793,733)	$ 1,676,012
Basic (loss)/income per share (in dollars per share)	$ (0.04)	$ 0.03	$ (0.05)	$ 0.02
Diluted (loss)/income per share (in dollars per share)	$ (0.04)	$ 0.03	$ (0.05)	$ 0.02
Weighted average shares outstanding: basic (in shares)	71,090,642	72,678,333	71,640,784	72,873,366
Weighted average shares outstanding: diluted (in shares)	71,090,642	73,332,888	71,640,784	73,699,226
Product Sales and Supportive Services [Member]
Revenues
Total revenues	$ 1,263,255	$ 8,615,765	$ 6,965,769	$ 15,936,637
Research and Development [Member]
Revenues
Total revenues	$ 4,614,911	$ 8,051,280	$ 7,235,421	$ 11,269,708

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net (loss)/income	$ (3,793,733)	$ 1,676,012
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and other amortization	264,778	256,237
Gain on change in fair value of warrant liability	0	(400,663)
Stock-based compensation	1,130,170	764,208
Write down of inventory, net	518,551	157,740
Deferred income taxes, net	(1,341,358)	(617,207)
Changes in assets and liabilities:
Accounts receivable	39,380,073	64,052,328
Inventory	(11,742,564)	2,921,257
Prepaid expenses and other assets	(1,109,768)	(592,168)
Accounts payable, accrued expenses and other liabilities	(1,935,092)	1,582,679
Income tax payable	(1,297,850)	(18,572,423)
Deferred revenue	793,764	3,270,658
Net cash provided by operating activities	20,866,971	54,498,658
Cash flows from investing activities:
Capital expenditures	(21,686)	0
Cash used in investing activities	(21,686)	0
Cash flows from financing activities:
Payment of employee tax obligations for common stock tendered	(214,794)	(12,533)
Repurchase of common stock	(11,072,511)	(10,149,704)
Payment of dividend	(32,135,118)	(32,944,314)
Cash used in financing activities	(43,422,423)	(43,106,551)
Net (decrease)/increase in cash and cash equivalents	(22,577,138)	11,392,107
Cash and cash equivalents at the beginning of period	98,790,622	103,138,819
Cash and cash equivalents at end of period	76,213,484	114,530,926
Supplemental disclosure of non-cash financing activities:
Conversion of warrant to common stock	$ 0	$ 6,120,778

Note 1 - Condensed Consolidated

Note 1 - Condensed Consolidated Financial Statements	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Condensed Consolidated Financial Statements The financial statements of SIGA Technologies, Inc. (“we,” “our,” “us,” “SIGA” or the “Company”) are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission for quarterly reports on Form 10 December 31, 2022 2022 10 March 2, 2023 ( 2022 10 not 2022 10 2022 not three six June 30, 2023 not

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Revenue Recognition The Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers 606” June 30, 2023 six four Note 3 June 30, 2023 July, two 19C $138.2 not 24 six three Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Contract modifications may not The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A portion of the Company's revenue is derived from long-term contracts that span multiple years. All of the Company’s revenue related to current research and development performance obligations is recognized over time, because the customer simultaneously receives and consumes the benefits provided by the services as the Company performs these services. The Company recognizes revenue related to these services based on the progress toward complete satisfaction of the performance obligation and measures this progress under an input method, which is based on the Company’s cost incurred relative to total estimated costs. Under this method, progress is measured based on the cost of resources consumed (i.e., cost of third third Contract Balances The timing of revenue recognition, billings and cash collections may June 30, 2023 six June 30, 2023

Note 3 - Procurement Contracts

Note 3 - Procurement Contracts and Research Agreements	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Procurement Contract and Research Agreements [Text Block]	3. 19C On September 10, 2018, July 31, 2023, "19C five may ten 19C The base period of performance specifies potential payments of approximately $51.7 million for the following activities: payments of approximately $11.1 million for the delivery of approximately 35,700 courses of oral TPOXX® to the Strategic Stockpile; payments of $8.0 million for the manufacture of 20,000 courses of final drug product of IV TPOXX® ("IV FDP"), of which $3.2 million of payments are related to the manufacture of bulk drug substance ("IV BDS") to be used in the manufacture of IV FDP; payments of approximately $32.0 million to fund reimbursed activities; and payments of approximately $0.6 million for supportive procurement activities. As of June 30, 2023 December 31, 2021, 2022, The options that have been exercised to date provide for payments up to approximately $407.1 million. There are exercised options for the following activities: payments up to $11.2 million for the procurement of raw materials used in the 2020 June 30, 2023 the delivery (and related procurement of raw materials) of oral TPOXX® to the Strategic Stockpile; $10.2 million for the completed manufacture of IV BDS, which has been recorded as deferred revenue as of June 30, 2023 ; and $ Une xercised options specify potential payments up to approx The options related to IV TPOXX® are divided into two may none 19C three three not two three two three 64,000 Revenues in connection with the 19C 19C three June 30, 2023 2022 six June 30, 2023 2022 six June 30, 2022 three June 30, 2022 three six June 30, 2023 U.S. Department of Defense Procurement Contracts On May 12, 2022, #1" #1 second 2022, #1. third 2022, September 2022 On September 28, 2022, #2" #2 In March 2023, March 2023 #2 International Procurement Contracts As of July 31, 2023, two April 2023 July 2023. In addition to the above-mentioned contracts with firm commitments, the Company has a contract with the Canadian Department of National Defence ( "CDND") under which the CDND has an option until March 31, 2024, April 2020, 2023, In 2022, 13 2022, 2022. Under the International Promotion Agreement, Meridian is the counterparty in connection with international contracts for oral TPOXX® and SIGA is responsible for manufacture and delivery of any oral TPOXX® purchased thereunder. Under the terms of the International Promotion Agreement, as amended, which has an initial term that expires on May 31, 2024, not Sales to international customers pursuant to the International Promotion Agreement are invoiced and collected by Meridian, and such collections are remitted, less Meridian's fees, to the Company under a quarterly process specified in the International Promotion Agreement. The fee Meridian retains pursuant to the International Promotion Agreement is a specified percentage of the collected proceeds of sales of oral TPOXX® net of certain expenses, for calendar years in which customer collected amounts net of such expenses are less than or equal to a specified threshold, and a higher specified percentage of such collected net proceeds for calendar years in which such net collected amounts exceed the specified threshold. Revenue in connection with international procurement contracts for the delivery of product are recognized at a point in time on a gross basis, as the Company acts as the principal in the transaction. During the three six June 30, 2023 three six June 30, 2022 Research Agreements and Grants In July 2019, January 31, 2025. June 30, 2023 three June 30, 2023 2022 six June 30, 2023 2022 Contracts and grants include, among other things, options that may may not may not

Note 4 - Inventory

Note 4 - Inventory	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. Inventory Inventory includes costs related to the manufacture of TPOXX®. Inventory consisted of the following: As of June 30, 2023 December 31, 2022 Raw materials $ 4,039,460 $ 6,370,581 Work in-process 37,447,497 27,038,845 Finished goods 9,010,146 5,863,664 Inventory $ 50,497,103 $ 39,273,090 For the three and six months ended June 30, 2023, cost of goods sold included a net-inventory related loss of $0.5 million. This loss is due to the impairment of a manufacturing batch.

Note 5 - Property, Plant and Eq

Note 5 - Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. Property, Plant and Equipment Property, plant and equipment consisted of the following: As of June 30, 2023 December 31, 2022 Leasehold improvements $ 2,420,028 $ 2,420,028 Computer equipment 470,830 449,143 Furniture and fixtures 347,045 347,045 Operating lease right-of-use assets 3,678,647 3,678,647 6,916,550 6,894,863 Less - accumulated depreciation and amortization (5,311,328 ) (5,046,549 ) Property, plant and equipment, net $ 1,605,222 $ 1,848,314 Depreciation and amortization expense on property, plant, and equipment was $0.3 million for each of the six June 30, 2023 2022

Note 6 - Accrued Expenses and O

Note 6 - Accrued Expenses and Other Current Liabilities	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	6. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of June 30, 2023 December 31, 2022 Deferred revenue $ 11,374,910 $ 10,581,146 Research and development vendor costs 1,962,683 1,551,920 Compensation 1,479,651 2,378,035 Other 1,331,903 1,245,353 Professional fees 729,513 536,997 Lease liability, current portion 545,558 528,170 Inventory 470,768 31,160 Accrued expenses and other current liabilities $ 17,894,986 $ 16,852,781

Note 7 - Financial Instruments

Note 7 - Financial Instruments	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	7. Financial Instruments 2016 On September 2, 2016, 2020. September 2, 2016 November 16, 2016. 2022, December 31, 2022. six June 30, 2022

Note 8 - Fair Value of Financia

Note 8 - Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Fair Value Disclosures [Text Block]	8. Fair Value of Financial Instruments The carrying value of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other current liabilities, and income tax payable approximates fair value due to the relatively short maturity of these instruments. Prior to being fully exercised, common stock warrants, which were classified as a liability, were recorded at their fair market value as of each reporting period. The measurement of fair value requires the use of techniques based on observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The inputs create the following fair value hierarchy: • Level 1 • Level 2 not • Level 3 third There were no six June 30, 2023 June 30, 2023 December 31, 2022 1 2 June 30, 2023 December 31, 2022 2 no 3 June 30, 2023 December 31, 2022

Note 9 - Per Share Data

Note 9 - Per Share Data	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	9. Per Share Data The Company computes, presents and discloses earnings per share in accordance with the authoritative guidance, which specifies the computation, presentation and disclosure requirements for earnings per share of entities with publicly held common stock or potential common stock. The objective of basic EPS is to measure the performance of an entity over the reporting period by dividing income (loss) by the weighted average shares outstanding. The objective of diluted EPS is consistent with that of basic EPS, except that it also gives effect to all potentially dilutive common shares outstanding during the period. The following is a reconciliation of the basic and diluted loss per share computation: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net (loss)/income for basic earnings per share $ (2,875,476 ) $ 2,037,062 $ (3,793,733 ) $ 1,676,012 Less: Change in fair value of warrants and cash-based RSUs — 49,559 — 400,663 Net (loss)/income, adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share $ (2,875,476 ) $ 1,987,503 $ (3,793,733 ) $ 1,275,349 Weighted-average shares 71,090,642 72,678,333 71,640,784 72,873,366 Effect of potential common shares — 654,555 — 825,860 Weighted-average shares: diluted 71,090,642 73,332,888 71,640,784 73,699,226 (Loss)/Income per share: basic $ (0.04 ) $ 0.03 $ (0.05 ) $ 0.02 (Loss)/Income per share: diluted $ (0.04 ) $ 0.03 $ (0.05 ) $ 0.02 For the three six June 30, 2022 not three six June 30, 2022 three six June 30, 2022 For the three six June 30, 2023 Three Months Ended June 30, Six Months Ended June 30, 2023 2023 Stock options 231,570 229,248 Restricted stock units (1) 428,566 362,360 ( 1 three June 30, 2023 six June 30, 2023

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	10. From time to time, we may not Purchase Commitments In the course of our business, the Company regularly enters into agreements with third not June 30, 2023

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	11. Related Party Transactions Real Estate Leases On May 26, 2017, ten 31 62 nd first sixty-three first six first sixty-fourth first second five three six June 30, 2023 June 30, 2023 Board of Directors and Outside Consultant Effective June 13, 2023, June 30, 2023

Note 12 - Revenues by Geographi

Note 12 - Revenues by Geographic Region	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	12. Revenues by Geographic Region Revenues by geographic region were as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 United States $ 4,646,983 $ 11,715,302 $ 12,970,007 $ 22,254,602 International Asia-Pacific — 4,929,423 — 4,929,423 Canada — — — — Europe, Middle East and Africa (EMEA) 1,231,183 — 1,231,183 — Other — 22,320 — 22,320 Total International 1,231,183 4,951,743 1,231,183 4,951,743 Total revenues $ 5,878,166 $ 16,667,045 $ 14,201,190 $ 27,206,345

Note 13 - Income Taxes

Note 13 - Income Taxes	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	13. Income Taxes The Company’s provision for income taxes consists of federal and state taxes, as applicable, in amounts necessary to align the Company’s year-to-date tax provision with the effective rate that it expects to achieve for the full year. Each quarter the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as necessary. For the three June 30, 2023 2022 For the six June 30, 2023 2022 The effective tax rate for the three June 30, 2023 three June 30, 2022 three June 30, 2023 162 The effective tax rate for the six June 30, 2023 six June 30, 2022 six June 30, 2023 162 The Inflation Reduction Act of 2022 August 16, 2022. three $1 not Effective beginning in fiscal 2022, 2017 5 15 not

Note 14 - Equity

Note 14 - Equity	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Equity [Text Block]	14. The tables below present changes in stockholders' equity for the three six June 30, 2023 2022 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2023 71,535,268 $ 7,154 $ 234,366,497 $ (72,280,191 ) $ — $ 162,093,460 Net loss — — — (2,875,476 ) — (2,875,476 ) Repurchase of common stock (including excise tax) (596,900 ) (60 ) — (3,515,396 ) — (3,515,456 ) Issuance of common stock upon vesting of RSUs 144,576 15 (15 ) — — — Payment of common stock tendered for employee stock-based compensation tax obligations — — (214,794 ) — — (214,794 ) Cash dividend ($0.45 per share) — — — (32,135,118 ) — (32,135,118 ) Stock-based compensation — — 721,440 — — 721,440 Balances at June 30, 2023 $ 71,082,944 $ 7,109 $ 234,873,128 $ (110,806,181 ) $ — $ 124,074,056 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2022 72,675,190 $ 7,268 $ 233,957,767 $ (63,804,993 ) $ — $ 170,160,042 Net loss — — — (3,793,733 ) — (3,793,733 ) Repurchase of common stock (including excise tax) (1,736,822 ) (174 ) — (11,072,337 ) — (11,072,511 ) Issuance of common stock upon vesting of RSUs 144,576 15 (15 ) — — — Payment of common stock tendered for employee stock-based compensation tax obligations — — (214,794 ) — — (214,794 ) Cash dividend ($0.45 per share) — — — (32,135,118 ) — (32,135,118 ) Stock-based compensation — — 1,130,170 — — 1,130,170 Balances at June 30, 2023 71,082,944 $ 7,109 $ 234,873,128 $ (110,806,181 ) $ — $ 124,074,056 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2022 72,566,367 $ 7,256 $ 226,426,529 $ (58,696,989 ) $ — $ 167,736,796 Net income — — — 2,037,062 — 2,037,062 Repurchase of common stock (494,979 ) (49 ) — (3,576,873 ) — (3,576,922 ) Issuance of common stock upon vesting of RSUs 127,856 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($0.45 per share) — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 395,454 — — 395,454 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2021 73,543,602 $ 7,354 $ 226,070,308 $ (51,763,255 ) $ — $ 174,314,407 Net income — — — 1,676,012 — 1,676,012 Repurchase of common stock (1,474,781 ) (147 ) — (10,149,557 ) — (10,149,704 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,973 ) — (12,533 ) — — (12,533 ) Issuance of common stock upon vesting of RSUs 132,396 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($0.45 per share) — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 764,208 — — 764,208 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 On August 2, 2021, may December 31, 2023. fourth 2021. may may 10b5 1 1934, three six June 30, 2023 three six June 30, 2023 On May 4, 2023, June 1, 2023 May 16, 2023.

Note 15 - Leases

Note 15 - Leases	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	15. The Company leases its Corvallis, Oregon, facilities and office space under an operating lease, which was signed on November 3, 2017 January 1, 2018. December 31, 2019 two one two three second 2019, first December 31, 2021. second 2021, second December 31, 2024. second second 2021. On May 26, 2017 ten no Operating lease costs totaled $0.1 million for each of the three June 30, 2023 2022 six June 30, 2023 2022 three June 30, 2023 2022 six June 30, 2023 2022 June 30, 2023 Future cash flows under operating leases as of June 30, 2023 2023 $ 279,946 2024 678,627 2025 406,994 2026 409,971 2027 165,916 Total undiscounted cash flows under leases 1,941,454 Less: Imputed interest (153,208 ) Present value of lease liabilities $ 1,788,246 As of June 30, 2023

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition The Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers 606” June 30, 2023 six four Note 3 June 30, 2023 July, two 19C $138.2 not 24 six three Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Contract modifications may not The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A portion of the Company's revenue is derived from long-term contracts that span multiple years. All of the Company’s revenue related to current research and development performance obligations is recognized over time, because the customer simultaneously receives and consumes the benefits provided by the services as the Company performs these services. The Company recognizes revenue related to these services based on the progress toward complete satisfaction of the performance obligation and measures this progress under an input method, which is based on the Company’s cost incurred relative to total estimated costs. Under this method, progress is measured based on the cost of resources consumed (i.e., cost of third third Contract Balances The timing of revenue recognition, billings and cash collections may June 30, 2023 six June 30, 2023

Note 4 - Inventory (Tables)

Note 4 - Inventory (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	As of June 30, 2023 December 31, 2022 Raw materials $ 4,039,460 $ 6,370,581 Work in-process 37,447,497 27,038,845 Finished goods 9,010,146 5,863,664 Inventory $ 50,497,103 $ 39,273,090 For the three and six months ended June 30, 2023, cost of goods sold included a net-inventory related loss of $0.5 million. This loss is due to the impairment of a manufacturing batch.

Note 5 - Property, Plant and _2

Note 5 - Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of June 30, 2023 December 31, 2022 Leasehold improvements $ 2,420,028 $ 2,420,028 Computer equipment 470,830 449,143 Furniture and fixtures 347,045 347,045 Operating lease right-of-use assets 3,678,647 3,678,647 6,916,550 6,894,863 Less - accumulated depreciation and amortization (5,311,328 ) (5,046,549 ) Property, plant and equipment, net $ 1,605,222 $ 1,848,314

Note 6 - Accrued Expenses and_2

Note 6 - Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	As of June 30, 2023 December 31, 2022 Deferred revenue $ 11,374,910 $ 10,581,146 Research and development vendor costs 1,962,683 1,551,920 Compensation 1,479,651 2,378,035 Other 1,331,903 1,245,353 Professional fees 729,513 536,997 Lease liability, current portion 545,558 528,170 Inventory 470,768 31,160 Accrued expenses and other current liabilities $ 17,894,986 $ 16,852,781

Note 9 - Per Share Data (Tables

Note 9 - Per Share Data (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net (loss)/income for basic earnings per share $ (2,875,476 ) $ 2,037,062 $ (3,793,733 ) $ 1,676,012 Less: Change in fair value of warrants and cash-based RSUs — 49,559 — 400,663 Net (loss)/income, adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share $ (2,875,476 ) $ 1,987,503 $ (3,793,733 ) $ 1,275,349 Weighted-average shares 71,090,642 72,678,333 71,640,784 72,873,366 Effect of potential common shares — 654,555 — 825,860 Weighted-average shares: diluted 71,090,642 73,332,888 71,640,784 73,699,226 (Loss)/Income per share: basic $ (0.04 ) $ 0.03 $ (0.05 ) $ 0.02 (Loss)/Income per share: diluted $ (0.04 ) $ 0.03 $ (0.05 ) $ 0.02
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2023 Stock options 231,570 229,248 Restricted stock units (1) 428,566 362,360

Note 12 - Revenues by Geograp_2

Note 12 - Revenues by Geographic Region (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 United States $ 4,646,983 $ 11,715,302 $ 12,970,007 $ 22,254,602 International Asia-Pacific — 4,929,423 — 4,929,423 Canada — — — — Europe, Middle East and Africa (EMEA) 1,231,183 — 1,231,183 — Other — 22,320 — 22,320 Total International 1,231,183 4,951,743 1,231,183 4,951,743 Total revenues $ 5,878,166 $ 16,667,045 $ 14,201,190 $ 27,206,345

Note 14 - Equity (Tables)

Note 14 - Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2023 71,535,268 $ 7,154 $ 234,366,497 $ (72,280,191 ) $ — $ 162,093,460 Net loss — — — (2,875,476 ) — (2,875,476 ) Repurchase of common stock (including excise tax) (596,900 ) (60 ) — (3,515,396 ) — (3,515,456 ) Issuance of common stock upon vesting of RSUs 144,576 15 (15 ) — — — Payment of common stock tendered for employee stock-based compensation tax obligations — — (214,794 ) — — (214,794 ) Cash dividend ($0.45 per share) — — — (32,135,118 ) — (32,135,118 ) Stock-based compensation — — 721,440 — — 721,440 Balances at June 30, 2023 $ 71,082,944 $ 7,109 $ 234,873,128 $ (110,806,181 ) $ — $ 124,074,056 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2022 72,675,190 $ 7,268 $ 233,957,767 $ (63,804,993 ) $ — $ 170,160,042 Net loss — — — (3,793,733 ) — (3,793,733 ) Repurchase of common stock (including excise tax) (1,736,822 ) (174 ) — (11,072,337 ) — (11,072,511 ) Issuance of common stock upon vesting of RSUs 144,576 15 (15 ) — — — Payment of common stock tendered for employee stock-based compensation tax obligations — — (214,794 ) — — (214,794 ) Cash dividend ($0.45 per share) — — — (32,135,118 ) — (32,135,118 ) Stock-based compensation — — 1,130,170 — — 1,130,170 Balances at June 30, 2023 71,082,944 $ 7,109 $ 234,873,128 $ (110,806,181 ) $ — $ 124,074,056 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2022 72,566,367 $ 7,256 $ 226,426,529 $ (58,696,989 ) $ — $ 167,736,796 Net income — — — 2,037,062 — 2,037,062 Repurchase of common stock (494,979 ) (49 ) — (3,576,873 ) — (3,576,922 ) Issuance of common stock upon vesting of RSUs 127,856 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($0.45 per share) — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 395,454 — — 395,454 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2021 73,543,602 $ 7,354 $ 226,070,308 $ (51,763,255 ) $ — $ 174,314,407 Net income — — — 1,676,012 — 1,676,012 Repurchase of common stock (1,474,781 ) (147 ) — (10,149,557 ) — (10,149,704 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,973 ) — (12,533 ) — — (12,533 ) Issuance of common stock upon vesting of RSUs 132,396 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($0.45 per share) — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 764,208 — — 764,208 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854

Note 15 - Leases (Tables)

Note 15 - Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	2023 $ 279,946 2024 678,627 2025 406,994 2026 409,971 2027 165,916 Total undiscounted cash flows under leases 1,941,454 Less: Imputed interest (153,208 ) Present value of lease liabilities $ 1,788,246

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies 1 (Details Textual) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 59
Unbilled Receivables, Current	3.8
Contract with Customer, Liability, Revenue Recognized	$ 0.1
Research and Development [Member]
Revenue, Performance Obligation, Number of Obligations	6
Manufacture and Delivery [Member]
Revenue, Performance Obligation, Number of Obligations	4

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies 2 (Details Textual)	Jun. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-03-31 | Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	3 years

Note 3 - Procurement Contract_2

Note 3 - Procurement Contracts and Research Agreements (Details Textual) $ in Thousands						1 Months Ended	3 Months Ended				6 Months Ended		12 Months Ended
	Apr. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 28, 2022 USD ($)	May 12, 2022 USD ($)	Sep. 10, 2018 USD ($)	Jul. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jul. 31, 2019 USD ($)
Contract with Customer, Liability, Revenue Recognized											$ 100
The 19C BARDA Contract [Member]
Number of Courses to Be Delivered					1,488,000
Government Contract, Value of Award							$ 602,500				602,500
Government Contract, Base Period, Value of Award for Delivery and Support Activities					$ 51,700		51,700				$ 51,700
Base Period of Performance (Year)											5 years
Government Contract Value Related To Exercised Options											$ 407,100
Government Contract, Value, Payments Related to Exercised Options, Procurement of Raw Materials							143,700				$ 143,700
Base Period of Performance, Exercise of Options, Term (Year)											10 years
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Delivery of Courses					$ 11,100
Government Contract, Base Period, Number of Deliveries					35,700
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Manufacture of Courses					$ 8,000
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Advanced Development					32,000
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Supportive Procurement Activities					$ 600
Proceeds from Delivery of Courses											$ 11,100
Number of Courses Delivered											35,700
Proceeds from Other Base Period Activities											$ 21,300
Contract with Customer, Liability, Revenue Recognized										$ 0
Government Contract, Value, Payments Remaining Related to Exercised Options											407,100
Government Contract, Value, Payments Currently Specified as Unexercised Options											143,700
Government Contract, Value of Unexercised Options, Supportive Procurement Activities								$ 5,600
The 19C BARDA Contract [Member] | Transferred at Point in Time [Member]
Contract with Customer, Liability, Revenue Recognized										0		$ 7,200
The 19C BARDA Contract [Member] | IV TPOXX [Member]
Government Contract, Base Period, Number of Courses Manufactured					20,000
Government Contract, Value, Payments Related to Exercised Options, Funding of Post-Marketing Activities														$ 3,600
Government Contract, Value, Payments Related to Unexercised Options, Delivery of Courses							112,500				112,500
Government Contract, Value, Payments Related to Unexercised Options, Funding of Post-Marketing Activities							$ 10,200				$ 10,200
Number of Manufacturing Steps							2				2
The 19C BARDA Contract [Member] | IV BDS [Member]
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Manufacture of Courses					$ 3,200
Proceeds from the Manufacture of Courses											$ 3,200
Proceeds from the Delivery of Courses											4,300
Contract with Customer, Liability, Total							$ 10,200				$ 10,200				$ 3,200
Government Contract, Number of Options for Manufacture of Product							3				3
Government Contract, Courses Manufactured Upon Exercise of Options							64,000				64,000
The 19C BARDA Contract [Member] | IV FDP Containing IV BDS [Member]
Contract with Customer, Liability, Total		$ 300					$ 20,400				$ 20,400		$ 300
Contract with Customer, Liability, Revenue Recognized													2,900
Government Contract, Value, Payments Currently Specified as Unexercised Options, Manufacture of Courses							$ 51,200				$ 51,200
The 19C BARDA Contract [Member] | Oral TPOXX [Member]
Number of Courses to Be Delivered							1,100,000				1,100,000
Government Contract, Value, Payments Related to Exercised Options, Procurement of Raw Materials							$ 11,200	225,100			$ 11,200
Government Contract, Value, Payments Related to Exercised Options, Delivery of Courses							326,500				326,500
Government Contract, Value, Payments Related to Exercised Options, Funding of Post-Marketing Activities																$ 14,600
Proceeds from Payments Received for Post-marketing Activities											7,700
The 19C BARDA Contract [Member] | IV FDP [Member]
Government Contract, Value, Payments Currently Specified as Unexercised Options, Manufacture of Courses							$ 25,600				$ 25,600
Government Contract, Number of Options for Manufacture of Product							3				3
Government Contract, Courses Manufactured Upon Exercise of Options							64,000				64,000
The 19C BARDA Contract [Member] | Maximum [Member]
Number of Courses to Be Delivered					212,000
IC BARDA [Member] | Transferred over Time [Member]
Contract with Customer, Liability, Revenue Recognized							$ 500			1,300	$ 2,100	1,900
Government Contract, Value, Payments Currently Specified as Unexercised Options, Manufacture of Courses							10,200				10,200
Government Contract, Value, Payments Related to Unexercised Options, Funding of Post-Marketing Activities							25,600				25,600
U.S. Department of Defense (“DoD”) [Member] | Oral TPOXX [Member]
Contract with Customer, Liability, Revenue Recognized								5,100		3,600
Government Contract, Value, Payments Currently Specified as Unexercised Options			$ 5,500	$ 3,800
Government Contract, Value Ordered			$ 5,100	$ 3,600
Government Contract, Value, Option Exercised								5,500	$ 3,800
International Procurement [Member]
Contract with Customer, Liability, Revenue Recognized							1,200			5,000	1,200	5,000
International Procurement [Member] | Oral TPOXX [Member]
Government Contract, Value of Award		77,000						$ 8,000					77,000
Contract with Customer, Liability, Revenue Recognized	$ 1,000	8,000											71,000
Government Contract, Value, Payments Currently Specified as Unexercised Options											6,000
International Procurement [Member] | Oral TPOXX [Member] | CANADA
Government Contract, Value of Award		39,000											39,000
International Procurement [Member] | Oral TPOXX [Member] | Europe, Asia Pacific and the Middle East [Member]
Government Contract, Value of Award		$ 38,000											$ 38,000
International Procurement [Member] | Oral TPOXX [Member] | Scenario, Plan [Member]
Government Contract, Value of Award							14,000				14,000
International Procurement [Member] | Oral TPOXX [Member] | Subsequent Event [Member]
Contract with Customer, Liability, Revenue Recognized						$ 7,000
The PEP Label Expansion R & D Contract with the Department of Defense [Member]
Government Contract, Value of Award																	$ 19,500
Contract with Customer, Liability, Revenue Recognized							4,000			$ 6,600	5,500	$ 8,900
Government Contract, Initial Award																	12,400
Government Contract, Increased Value of Award																	$ 27,000
Contract with Customer, Liability, Remaining Revenue Recognized							$ 900				$ 900

Note 4 - Inventory - Inventory

Note 4 - Inventory - Inventory (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Raw materials	$ 4,039,460	$ 6,370,581
Work in-process	37,447,497	27,038,845
Finished goods	9,010,146	5,863,664
Inventory	$ 50,497,103	$ 39,273,090

Note 5 - Property, Plant and _3

Note 5 - Property, Plant and Equipment (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Depreciation, Depletion and Amortization	$ 264,778	$ 256,237

Note 5 - Property, Plant and _4

Note 5 - Property, Plant and Equipment - Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Property, plant and equipment, gross	$ 6,916,550	$ 6,894,863
Less - accumulated depreciation and amortization	(5,311,328)	(5,046,549)
Property, plant and equipment, net	1,605,222	1,848,314
Other Assets [Member]
Property, plant and equipment, gross	3,678,647	3,678,647
Leasehold Improvements [Member]
Property, plant and equipment, gross	2,420,028	2,420,028
Computer Equipment [Member]
Property, plant and equipment, gross	470,830	449,143
Furniture and Fixtures [Member]
Property, plant and equipment, gross	$ 347,045	$ 347,045

Note 6 - Accrued Expenses - Acc

Note 6 - Accrued Expenses - Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Deferred revenue	$ 11,374,910	$ 10,581,146
Research and development vendor costs	1,962,683	1,551,920
Compensation	1,479,651	2,378,035
Other	1,331,903	1,245,353
Professional fees	729,513	536,997
Inventory	470,768	31,160
Accrued expenses and other current liabilities	17,894,986	16,852,781
Accrued Expenses and Other Current Liabilities [Member]
Lease liability, current portion	$ 545,558	$ 528,170

Note 7 - Financial Instruments

Note 7 - Financial Instruments (Details Textual) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Sep. 02, 2016
Fair Value Adjustment of Warrants	$ 0	$ 49,559	$ 0	$ 400,663
The 2016 Warrant [Member]
Class of Warrant or Right Outstanding, Common Stock Value Used to Determine Number of Shares Called						$ 4,000,000
Class of Warrant or Right Outstanding, Common Stock Price Per Share Used to Determine Number of Shares Called (in dollars per share)						$ 2.29
Class of Warrant or Right, Subscription Price of Warrants or Rights (in dollars per share)						1.50
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)						$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					0	2,700
Fair Value Adjustment of Warrants				$ (400,000)

Note 8 - Fair Value of Financ_2

Note 8 - Fair Value of Financial Instruments (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 1 [Member]
Cash and Cash Equivalents, Fair Value Disclosure	$ 53,500	$ 100
Fair Value, Inputs, Level 2 [Member]
Cash and Cash Equivalents, Fair Value Disclosure	$ 0	$ 40,500

Note 9 - Per Share Data (Detail

Note 9 - Per Share Data (Details Textual) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		51,930		53,353
Restricted Stock Units RSU Settled in Cash [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	36,384		33,559

Note 9 - Per Share Data - Recon

Note 9 - Per Share Data - Reconciliation of the Basic and Diluted Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net (loss)/income	$ (2,875,476)	$ 2,037,062	$ (3,793,733)	$ 1,676,012
Less: Change in fair value of warrants and cash-based RSUs	0	49,559	0	400,663
Net (loss)/income, adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share	$ (2,875,476)	$ 1,987,503	$ (3,793,733)	$ 1,275,349
Weighted-average shares (in shares)	71,090,642	72,678,333	71,640,784	72,873,366
Effect of potential common shares (in shares)	0	654,555	0	825,860
Weighted-average shares: diluted (in shares)	71,090,642	73,332,888	71,640,784	73,699,226
Basic (loss)/income per share (in dollars per share)	$ (0.04)	$ 0.03	$ (0.05)	$ 0.02
Diluted (loss)/income per share (in dollars per share)	$ (0.04)	$ 0.03	$ (0.05)	$ 0.02

Note 9 - Per Share Data - Antid

Note 9 - Per Share Data - Antidilutive Securities Excluded from Computation (Details) - shares		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive securities (in shares)			51,930		53,353
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)		231,570		229,248
Restricted Stock Units (RSUs) [Member]
Antidilutive securities (in shares)	[1]	428,566		362,360
[1]For the three months ended June 30, 2023, the total includes a weighted average of 36,384 units which are expected to settle in cash. For the six months ended June 30, 2023, the total includes a weighted average of 33,559 units which are expected to settle in cash

Note 10 - Commitments and Con_2

Note 10 - Commitments and Contingencies (Details Textual) $ in Millions	Jun. 30, 2023 USD ($)
Purchase Commitment, Remaining Minimum Amount Committed	$ 24.6

Note 11 - Related Party Trans_2

Note 11 - Related Party Transactions (Details Textual)		3 Months Ended	6 Months Ended
	May 26, 2017 USD ($) ft²	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)
Director [Member]
Accounts Payable and Accrued Liabilities		$ 0	$ 0
Consulting Agreement, Monthly Fee		20,000	20,000
MacAndrews and Forbes Incorporated [Member] | The New HQ Lease [Member]
Lessee, Operating Lease, Term of Contract (Year)	10 years
Area of Real Estate Property (Square Foot) | ft²	3,200
Monthly Rent During Initial Period	$ 25,333
Monthly Rent, Initial Period (Month)	63 months
Monthly Rent After Initial Period	$ 29,333
Monthly Facility Fee, Second Year	$ 3,333
Monthly Facility Fee, Yearly Rate Increase After Second Year	5%
Monthly Facility Fee, Final Year	$ 4,925
Operating Lease, Expense		100,000	200,000
Accounts Payable and Accrued Liabilities		$ 0	$ 0

Note 12 - Revenues by Geograp_3

Note 12 - Revenues by Geographic Region - Revenues by Geographic Region (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenues	$ 5,878,166	$ 16,667,045	$ 14,201,190	$ 27,206,345
UNITED STATES
Total revenues	4,646,983	11,715,302	12,970,007	22,254,602
Asia Pacific [Member]
Total revenues	0	4,929,423	0	4,929,423
CANADA
Total revenues	0	0	0	0
EMEA [Member]
Total revenues	1,231,183	0	1,231,183	0
Other [Member]
Total revenues	0	22,320	0	22,320
Non-US [Member]
Total revenues	$ 1,231,183	$ 4,951,743	$ 1,231,183	$ 4,951,743

Note 13 - Income Taxes (Details

Note 13 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income (Loss) Attributable to Parent, before Tax	$ (3,400,000)	$ 3,200,000	$ (4,700,000)	$ 2,100,000
Income Tax Expense (Benefit)	$ (572,186)	$ 1,155,581	$ (871,608)	$ 452,175
Effective Income Tax Rate Reconciliation, Percent	16.60%	36.20%	18.70%	21.20%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%		21%

Note 14 - Equity (Details Textu

Note 14 - Equity (Details Textual) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended	6 Months Ended
	May 04, 2023	Jun. 30, 2023	Jun. 30, 2023	Aug. 02, 2021
Stock Repurchase Program, Authorized Amount				$ 50
Stock Repurchased During Period, Shares (in shares)		0.6	1.7
Special Dividend [Member]
Common Stock, Dividends, Per Share, Declared (in dollars per share)	$ 0.45
Dividends	$ 32
New Repurchase Authorization [Member]
Stock Repurchased During Period, Shares (in shares)		3.5	11
Excise Tax on Corporate Shares Repurchased		$ 0.1

Note 14 - Equity - Changes in S

Note 14 - Equity - Changes in Stockholders' Equity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Balances	$ 162,093,460	$ 167,736,796	$ 170,160,042	$ 174,314,407
Net (loss)/income	$ (2,875,476)	2,037,062	$ (3,793,733)	1,676,012
Repurchase of common stock (including excise tax) (in shares)	(600,000)		(1,700,000)
Repurchase of common stock (including excise tax)	$ (3,515,456)	(3,576,922)	$ (11,072,511)	(10,149,704)
Issuance of common stock upon vesting of RSUs	0	0	0	0
Payment of common stock tendered for employee stock-based compensation tax obligations	(214,794)		(214,794)	(12,533)
Cash dividend ($0.45 per share)	(32,135,118)	(32,944,314)	(32,135,118)	(32,944,314)
Stock-based compensation	721,440	395,454	1,130,170	764,208
Issuance of common stock upon exercise of warrants		6,120,778		6,120,778
Cash dividend ($0.45 per share)	32,135,118	32,944,314	32,135,118	32,944,314
Balances	$ 124,074,056	$ 139,768,854	$ 124,074,056	$ 139,768,854
Common Stock [Member]
Balances (in shares)	71,535,268	72,566,367	72,675,190	73,543,602
Balances	$ 7,154	$ 7,256	$ 7,268	$ 7,354
Net (loss)/income	$ 0	$ 0	$ 0	$ 0
Repurchase of common stock (including excise tax) (in shares)	(596,900)	(494,979)	(1,736,822)	(1,474,781)
Repurchase of common stock (including excise tax)	$ (60)	$ (49)	$ (174)	$ (147)
Issuance of common stock upon vesting of RSUs (in shares)	144,576	127,856	144,576	132,396
Issuance of common stock upon vesting of RSUs	$ 15	$ 13	$ 15	$ 13
Payment of common stock tendered for employee stock-based compensation tax obligations	0		0	0
Cash dividend ($0.45 per share)	0	0	0	0
Stock-based compensation	0	$ 0	0	$ 0
Issuance of common stock upon exercise of warrants (in shares)		824,903		824,903
Issuance of common stock upon exercise of warrants		$ 82		$ 82
Cash dividend ($0.45 per share)	$ 0	$ 0	$ 0	$ 0
Payment of common stock tendered for employee stock-based compensation tax obligations (in shares)				(1,973)
Balances (in shares)	71,082,944	73,024,147	71,082,944	73,024,147
Balances	$ 7,109	$ 7,302	$ 7,109	$ 7,302
Additional Paid-in Capital [Member]
Balances	234,366,497	226,426,529	233,957,767	226,070,308
Net (loss)/income	0	0	0	0
Repurchase of common stock (including excise tax)	0	0	0	0
Issuance of common stock upon vesting of RSUs	(15)	(13)	(15)	(13)
Payment of common stock tendered for employee stock-based compensation tax obligations	(214,794)		(214,794)	(12,533)
Cash dividend ($0.45 per share)	0	0	0	0
Stock-based compensation	721,440	395,454	1,130,170	764,208
Issuance of common stock upon exercise of warrants		6,120,696		6,120,696
Cash dividend ($0.45 per share)	0	0	0	0
Balances	234,873,128	232,942,666	234,873,128	232,942,666
Retained Earnings [Member]
Balances	(72,280,191)	(58,696,989)	(63,804,993)	(51,763,255)
Net (loss)/income	(2,875,476)	2,037,062	(3,793,733)	1,676,012
Repurchase of common stock (including excise tax)	(3,515,396)	(3,576,873)	(11,072,337)	(10,149,557)
Issuance of common stock upon vesting of RSUs	0	0	0	0
Payment of common stock tendered for employee stock-based compensation tax obligations	0		0	0
Cash dividend ($0.45 per share)	(32,135,118)	(32,944,314)	(32,135,118)	(32,944,314)
Stock-based compensation	0	0	0	0
Issuance of common stock upon exercise of warrants		0		0
Cash dividend ($0.45 per share)	32,135,118	32,944,314	32,135,118	32,944,314
Balances	(110,806,181)	(93,181,114)	(110,806,181)	(93,181,114)
AOCI Attributable to Parent [Member]
Balances	0	0	0	0
Net (loss)/income	0	0	0	0
Repurchase of common stock (including excise tax)	0	0	0	0
Issuance of common stock upon vesting of RSUs	0	0	0	0
Payment of common stock tendered for employee stock-based compensation tax obligations	0		0	0
Cash dividend ($0.45 per share)	0	0	0	0
Stock-based compensation	0	0	0	0
Issuance of common stock upon exercise of warrants		0		0
Cash dividend ($0.45 per share)	0	0	0	0
Balances	$ 0	$ 0	$ 0	$ 0

Note 15 - Leases (Details Textu

Note 15 - Leases (Details Textual)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2019	May 26, 2017 ft²
Operating Lease, Cost	$ 100,000	$ 100,000		$ 300,000
Operating Lease, Payments	$ 200,000			$ 300,000	$ 300,000
Operating Lease, Weighted Average Remaining Lease Term (Year)	3 years 3 months			3 years 3 months
Operating Lease, Weighted Average Discount Rate, Percent	4.53%			4.53%
Operating Lease, Liability	$ 1,788,246			$ 1,788,246
Other Liabilities [Member]
Operating Lease, Liability	$ 1,200,000			$ 1,200,000
Facilities and Office Space in Corvallis Oregon [Member]
Lessee, Operating Lease, Number of Renewal Options						2
Two Years, Option Renewal Term [Member] | Facilities and Office Space in Corvallis Oregon [Member]
Lessee, Operating Lease, Renewal Term (Year)						2 years
Three Years, Option RenewalTerm [Member] | Facilities and Office Space in Corvallis Oregon [Member]
Lessee, Operating Lease, Renewal Term (Year)						3 years
Increase (Decrease) in Operating Right-of-use Assets			$ 700,000
The New HQ Lease [Member] | MacAndrews and Forbes Incorporated [Member]
Lessee, Operating Lease, Term of Contract (Year)							10 years
Area of Real Estate Property (Square Foot) | ft²							3,200

Note 15 - Leases - Future Undis

Note 15 - Leases - Future Undiscounted Cash Flows Under Operating Leases (Details)	Jun. 30, 2023 USD ($)
2023	$ 279,946
2024	678,627
2025	406,994
2026	409,971
2027	165,916
Total undiscounted cash flows under leases	1,941,454
Less: Imputed interest	(153,208)
Present value of lease liabilities	$ 1,788,246